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Abstract
Ascites is one of the major complications seen in various disease conditions in 
pets. Ascites is characterised by distension of the abdomen with accumulation of 
fluid of various colours and consistencies depending on the cause. The most common 
causes of ascites in pets include but not limited to the following health conditions: 
hypoproteinaemia, left-sided heart failure, congestive heart failure, cirrhosis, hepatic 
diseases, renal diseases, ancylostomosis and bacterial infection such as tuberculosis. 
Pathogenesis of ascites often emanate from portal hypertension, cirrhosis, hepa-
torenal syndrome, etc. Oftentimes the diagnosis of ascites could be cumbersome 
considering the myriad of diseases implicated in the condition. Standard diagnostic 
procedures include the following: physical examination, clinical examination, 
ultrasonography, computed tomography, serum ascites albumin gradient (SAAG), 
biochemical analysis such as triglyceride, urea and creatinine concentration, total 
protein, etc. Novel diagnostic procedures with possible clinical relevance include 
the following: leucocyte esterase reagent strip, platelet indices, tumour markers, 
etc. Diagnosis is made through standard diagnostic procedure, while special cases 
of idiopathic origin are detected through diagnostic laparotomy. Novel diagnostic 
procedures such as platelet indices, leucocyte esterase reagent strip and tumour 
markers would aid in easy diagnosis of ascites. Treatment of ascites is dependent on 
identification of the cause of ascites.
Keywords: ascites, SAAG, hepatorenal syndrome, diuretics, portal hypertension, 
abdominocentesis, hepatic, cardiac, abdominal effusion, abdominal drops
1. Introduction
Ascites is a term used to describe the condition of accumulation of fluid in the 
peritoneal cavity. The word “ascites” could be used interchangeably with other 
terms such as abdominal dropsy, abdominal effusion, peritoneal fluid excess, 
hydroperitoneum and peritoneal cavity fluid. Ascites represents a form of general 
systemic state which could manifest in diverse disease conditions in animals. This 
implies that ascites is only a clinical manifestation of an underlying disease condi-
tion and not a disease in real sense. It further shows that ascites is not a treatable 
condition except the cause is properly diagnosed and treated accordingly. Ascites 
is often diagnosed in dogs between the ages of 5 and 7 years [1]. Cases between the 
ages of 1 and 4 years have also been recorded. The occurrence of ascites in dogs 
may be breed dependent with higher incidences in Pomeranian (33.35%) than in 
Labrador retriever (20%), Boxer (16.66%), Doberman pinscher (13.37%), mon-
grels (10%) and least in Alsatian (6.66%) [1]. Ascites manifests in several disease 
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conditions such as hepatic disease, various types of neoplasm, portal hypertension, 
alteration in serum protein level (hypoproteinaemia), right-sided heart failure, 
decreased plasma oncotic pressure and increased permeability of capillary endothe-
lium sequel to inflammatory conditions, bacterial infection (tuberculosis), kidney 
malfunction, pre-hepatic portal hypertension, post-hepatic portal hypertension, 
trauma (rupture of lymphatic vessels, blood vessels, urinary bladder),
ancylostomosis peritonitis, bleeding disorders and malnutrition [2, 3]. Other 
conditions may include heartworm infection and pulmonary stenosis [4]. In gen-
eral, cardiac and hepatic disease conditions ranked highest as the cause of ascites in 
pets. Other manifesting signs which usually signify an underlying disease condition 
in ascetic pets may include syncope, vomiting, obtundation, seizure, anaemia which 
manifests as pale mucous membrane, weakness and rapid panting. The identifica-
tion and diagnosis of the cause of ascites may not be a straightforward procedure 
and could be complicated due to the several causative factors. The veterinarian 
however has to be guided by the medical adage “if you hear the sound of hoof first 
look for a horse before a zebra”. This only means that diagnosis should start with 
the basis of thorough physical examination of the entire body and clinical exami-
nations. A well and sequential conduction of physical and clinical examinations 
serves as a pointer to the underlying cause of ascites. However this may not always 
be so as diagnosis oftentimes is cumbersome. In such situations diagnosis would 
include a complete blood count which may reveal evidence of bacterial infection. 
Abdominal ultrasound/sonography is done to determine the abdominal content 
and aid in differentiating excess fluid accumulation from abdominal masses and 
organ enlargement. Knowledge of the blood biochemistry including total protein, 
albumin, creatinine and urea, liver enzymes and coagulation profile would help in 
revealing cases of hypoalbuminaemia, hypoproteinaemia and hepatic and kidney 
diseases [5]. Cardiac diseases may be diagnosed with the aid of electrocardiograph. 
Cardiac auscultation detects cases of cardiac murmurs and arrhythmia. Abdominal 
paracentesis is a useful procedure usually carried out to reduce the fluid level and 
alleviate complications of dyspnea. Paracentesis is a useful procedure in the man-
agement of ascites which is instituted in conjunction with appropriate treatment of 
the underlying cause. Once appropriate diagnosis is made, treatment usually comes 
easy by alleviating life-threatening conditions such as dyspnea and administering 
appropriate therapy as the case may be.
2. Classification of ascites
The purpose of this review is primarily focused on the various causes of ascites 
with emphasis on the hepatic origin. Based on this premise, ascites is classified 
broadly into hepatic, pre-hepatic and post-hepatic origin:
i. Pre-hepatic causes emanate from portal vein thrombosis, bacterial infection 
such as tuberculosis, malnutrition, hypoalbuminaemia and parasitic diseases 
such as strongyloidosis and entamoeba [6]. Other causes include trauma 
or rupture of the lymphatic vessels, blood vessels and urinary bladder, 
renal failure, lymphoma and neoplasm of various kinds including breast, 
bronchus, ovary, gastric, pancreatic or colonic neoplasms [7]. Up to 20% of 
neoplastic ascites arise from tumour of unknown origin [7].
ii. Post-hepatic causes might include congestive heart failure often linked with 
pulmonary hypertension, left-sided heart failure, right-sided heart failure, 
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constrictive pericarditis, Budd-Chiari syndrome and stricture web formation 
in the inferior vena cava [8, 9].
iii. Hepatic origin emanates from various hepatic diseases including cirrhosis, 
portal hypertension and hepatitis. Approximately 85% of portal hyperten-
sion results in cirrhosis [8–10].
Earlier classification of ascites was centred on two broad categories, transudates 
and exudates, based on the total protein concentration of ascetic fluid. High total 
protein (>2.5 g/l) was described as exudates, while low total protein (<2.5 g/l) as tran-
sudate [11]. Both transudates and exudates were subcategorised into modified transu-
dates and exudates based on the level of total protein concentration in the ascetic 
fluid. Transudates with <2.5 g/l of total protein usually occur with portal hypotension 
or hypoalbuminaemia [6]. Exudates with >2.5 g/l of total protein are associated with 
inflammatory disease conditions such as bacteria tuberculosis, neoplasm of unknown 
origin, pancreatitis, myxoedema, etc. Nevertheless, it has been observed that a 
total protein concentration of <2.5 g/l has an accuracy of only 56% [6] in detecting 
exudates from various conditions such as cardiac ascites and patients on diuretics and 
neoplasms [11]. The obvious challenge in the use of total protein concentration paved 
way to the discovery of serum ascites albumin gradient (SAAG) concentration as a 
more reliable tool in classification of ascites with efficacy ranging from 80 to 100% 
[11]. With the advent of SAAG, exudate ascites is replaced with (>1.1 g/l) high serum 
ascites albumin gradient and transudate with low (<1.1 g/l) serum ascites albumin 
gradient. The SAAG (>1.1 g/l) shows higher 94% sensitivity and 90% specificity in 
detecting portal hypertension than ascetic fluid total protein concentration of <2.5 g/
dl at percentage sensitivity and specificity of 78 and 50%, respectively [12]. The 
prognostic index value of SAAG was at 82–97% compared to total protein concentra-
tion at 38–85% [12]. Ascites from cardiac origin produces greater(>2.5g/dl) SAAG 
compared to cases of cirrhosis [13].
A more recent classification of ascites has endorsed the use of serum ascites 
albumin gradient (SAAG) in diagnosis of ascites [14]. The SAAG is derived by 
subtracting the ascetic fluid albumin level from the serum albumin level obtained 
on the same day [14]. Gradients greater than 1.1 g/dl indicate ascites of portal 
hypertension with an accuracy of 97–100% [14]. Gradients less than 1.1 g/dl are 
considered ascites of other sources other than portal hypertension such as neo-
plasm [15, 16] (Table 1).
High gradient (>1.1 g/l) SAAG Low gradient (<1.1 g/l) SAAG
Portal hypertension Bacterial infection
Cardiac diseases Peritoneal tuberculosis




Portal vein thrombosis Trauma and rupture of lymphatic and blood vessels
Hypoalbuminaemia Rupture of the urinary bladder, left-sided heart failure, right-sided 
heart failure, congestive heart failure
Table 1. 
Classification of ascites based on SAAG.
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3. Pathophysiology of ascites in cirrhosis
Ascites is one of the cardinal complications in liver cirrhosis in most patients [8]. 
Onset of ascites naturally connotes decompensated underlying liver cirrhosis which 
also signifies poor prognosis with short life expectancy [10, 17, 18]. Several factors 
contribute to the development of cirrhosis. The heart, for instance, plays an important 
role through a complex mechanism in the development of liver disease. The mecha-
nism through which the heart and liver affect each other in the development of ascites 
is yet to be fully elucidated [14]. Several circulatory abnormalities observed in cir-
rhotic patients promulgated the peripheral arterial vasodilation hypothesis proposed 
in the last century [19]. The circulatory abnormalities manifest as increased cardiac 
output, portal hypertension, peripheral vascular resistance, arterial hypotension and 
splanchnic vasodilation [6, 20]. Circulatory abnormalities from cardiac disease affect 
circulatory volume with a resultant decrease in tissue perfusion affecting majorly the 
kidney functionality [21]. Earlier in the disease, renal dysfunction is less expressed; 
however, with disease advancement the patient may experience difficulty in sodium 
excretion and consequent sodium and water retention [22]. Cirrhotic ascites basi-
cally develop from failure in renal excretion of sodium [22]. Different mechanisms 
also play a role in ascites in cirrhosis. Intrinsic factors including arterial vasodilation 
affect the blood pressure hormones such as the renin-angiotensin-aldosterone system 
(RAAS) which stimulates sodium reabsorption from the distal nephron [22]. The 
sympathetic nervous system (SNS) induces renal constriction and sodium reabsorp-
tion from the tubules with ascites [23, 24]. The heart, SNS and RAAS play a synergis-
tic role in sodium retention and development of ascites in cirrhosis.
3.1 Pathogenesis of portal hypertension in ascites
The portal vein is a major vein comprising of a group of veins which supply the 
visceral organs including the abdomen, pancreas, intestine, etc. These veins bifurcate 
into smaller vessels in the hepatic tissue. Intrinsic factors and disease conditions such 
as cirrhosis result in blockage of these tiny veins in the hepatic tissue increasing the 
blood pressure in the veins with resultant portal hypertension. Other causes of portal 
hypotension include portal vein thrombosis, schistosomosis, idiopathy, etc. Ascites 
develops in portal hypertension when the post-sinusoidal gradient is above 12 mmHg 
[25]. Portal hypertension elevates the hydrostatic pressure within the hepatic sinu-
soids permitting seepage of transudate into the peritoneal cavity [26, 27]. The extent 
of ascites’ development is dependent on the level of hydrostatic pressure [28] and less 
on oncotic plasma albumin pressure [26, 29]. Signs and symptoms of portal hyper-
tension include haematuria, dysentery, bloody vomitus due to spontaneous rupture 
and haemorrhage from varices, encephalopathy due to abnormal liver function and 
thrombocytopaenia. Factors such as abnormal increase in nitric oxide production  
and circulation of endogenous vasoconstriction such as catecholamines, leukotrienes 
and angiotensin II enhance hepatic vascular resistance and portal hypertension [30, 31].
3.1.1 Pathogenesis of hepatorenal syndrome in ascites
One of the complications of activation of RAAS and SNS in cirrhosis is the resultant 
renal vasoconstriction leading to decrease in renal perfusion and glomerular filtrate 
rate which progresses to renal impairment [21, 22, 32, 33]. In hepatorenal syndrome, 
there are no significant morphological changes in renal histology, while the patients 
largely retain normal tubular function [5, 21]. The kidney analyte and serum creatinine 
concentration does not increase until the glomerular filtration rate becomes markedly 
reduced below 40 ml/min [22]. Most patients with cirrhosis have their creatinine level 
below 1.2 mg/dl, and diagnosis of HRS is only made when the creatinine concentration 
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is higher than 1.5 mg/dl in the absence of other complicating aetiologies [22]. 
Hepatorenal syndrome manifests in two different types in cirrhotic patients. Type I 
HRS is a fulminating form of the disease rapidly progressing to acute renal failure often 
precipitated by variceal bleeding, septic infection and spontaneous bacteria peritonitis 
with poor prognosis of days to weeks [22]. Type 2 is a more chronic form of HRS. Most 
patients with this form of disease have a more stable creatinine concentration with only 
signs of refractory ascites due to unresponsive diuretics [34, 35].
With advancement in cirrhosis, there is also progressive increase in sodium 
and water reabsorption and decrease in renal blood flow and glomerular filtration 
[36]. Approximately 20% of cirrhotic patients with refractory ascites progress to 
HRS which results from severe liver and systemic circulatory dysfunction [28]. 
Hepatorenal syndrome results from marked overactivity of RAAS, SNS, AND and 
other endogenous vasoconstrictor factors which exceeds renal production of vaso-
dilatory substances [PGE2, prostacyclin, nitric oxide]. The imbalance from renal 
vasodilatory mechanism and the intrinsic vasoconstrictor enhances vasoconstriction 
and hypoperfusion and decreases GFR with ultimate result of renal failure [22].
4. Diagnosis of ascites
Usually there is no laid down procedure on the steps to diagnose ascites; however 
a systematic approach applied in various disease conditions is advantageous in mak-
ing appropriate diagnosis. A step-by-step approach normally starts with physical 
examination.
4.1 Algorithm of diagnosis in ascites
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4.1.1 Physical examinations
In physical examination, the patient is examined for the presence of ticks and 
fleas which would contribute in physical discomfort of the pet. Ticks’ infestation 
contributes in depletion of blood volume and anaemia. Anaemia is detected by the 
appearance of pale mucous membrane of the eye and the gum. Ectoparasitism from 
ticks’ infestation may result in malnutrition due to competition with the host for 
essential nutrients necessary for the synthesis of protein and albumin. This could 
result in hypoalbuminaemia/hypoproteinaemia and a decrease in plasma oncotic 
pressure enhancing vascular permeability and seepage of fluid in the abdominal 
cavity. A distended or pulsating jugular vein in the neck region may indicate car-
diovascular abnormality. Yellowish discoloration of the eye indicates jaundice and 
hepatic disease. Generalised lymphadenopathy may suggest lymphosarcoma and 
other inflammatory disease conditions. A “standback” observation reveals cases of 
dyspnea due to abdominal displacement of the diaphragm into the thoracic cavity 
compromising respiration. Respiratory distress could manifest in the form of rapid 
panting. Such condition presents a deviation from the normal respiratory pat-
tern, from coastal to costo-abdominal or abdominal pattern. Black tarry-coloured 
faeces from gastrointestinal bleeding may signify ancylostomosis and portal 
hypertension. Physical examination of the trunk reveals a distended abdomen. The 
content of the abdomen could either be by pregnancy, abdominal masses, fluid of 
various consistencies or organ enlargement. The diagnosis of ascites starts from 
differentiating these possibilities through various procedures. First is to carry out 
abdominal ballottement using clinched fist. This technique can be used to dif-
ferentiate abdominal masses from fluid. It can be used with other laboratory tests 
such as pregnancy test to rule out pregnancy. It however has some limitations in 
differentiating abdominal masses from organ enlargement. Abdominal ultrasound 
is a better option in differentiating abdominal contents. It has been proven effec-
tive in the detection of ascetic fluid, its site of production and differentiation of 
ascetic nature from transudates and exudates [11]. A recent research has shown the 
possibility of the use of echotexture of ascetic fluid in the detection of the cause of 
ascites in patients [11]. Abdominal paracentesis however is a very useful technique 
in differentiation of ascetic fluid [28].
4.1.2 Guidelines for paracentesis in a dog (author’s personal experience)
A well-applied paracentesis without contamination of abdominal content is 
essential in differentiation of ascetic fluid. To achieve this, the following steps 
should be strictly applied:
1. First apply caution by the use of proper restrain technique on the dog.
2. Gently place the dog on a lateral decumbency exposing the larger part of the 
ventral abdomen.
3. Swab the ventral abdomen less covered with haircoat, along the linea alba 
down to the ventral abdomen between the left and right hindlimbs. (Linea 
alba is the preferred site of paracentesis due to its less vascularisation and less 
chance of contamination of the fluid with blood from puncture vessels and 
abdominal organs when approached through a different site on the abdomen.)
4. Puncture the linea alba using a 21 gauge needle and 10 mL gauge syringe, and 
aspirate the fluid.
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5. Decant the content of the syringe into a clean and well-labelled tube for labora-
tory investigation.
6. Request for cytology of the fluid (Figure 1).
4.1.3 Diagnostic fluid markers in ascites
The colour of ascetic fluid is a very essential marker in the diagnosis of the cause 
of ascites. The colour ranges from clear fluid to yellowish, reddish and opaque with 
flakes of fibrin and debris depending on the aetiology. It is therefore important to 
observe the above guidelines in paracentesis in order to avoid false discolouration of 
the fluid, thus affecting correct diagnosis. Various colours of ascetic fluid signify a 
different aetiology as shown below [37]:
1. Pinkish discolouration of the fluid: This is often seen in cases of exudation 
of fluid from bacterial infection which may become purulent. The exudates 
are often turbid in consistency and contains more than 2.0 gm of protein and 
greater than 6000 cells/μL composed mostly of neutrophils with evidence of 
+++ bacterial infection. This type of fluid is considered a medical emergency to 
prevent development of sepsis.
2. Clear straw-coloured fluid: This type of fluid is described as modified transu-
date often characterised by the presence of fibrin cells and white blood cells 
such as neutrophils and lymphocytes. It is often seen in cases of long-standing 
ascites from various conditions including right-sided heart failure, cancerous 
growth and hepatic disease giving chance to invasion of fibrinogens.
3. Clear opaque fluid: This fluid is described as collection of pure transudate into 
the peritoneal cavity free from contamination except with few invasions of 
mesothelial cells and tissue macrophages. This ascites may be seen in cases of 
portal hypertension, hepatic diseases, osmotic gradient deficit (hypoalbumi-
naemia), protein losing enteropathy, kidney impairment and albuminuria.
4. Reddish discolouration of fluid: This is seen in cases of haemorrhages and 
collection of frank blood in the peritoneal cavity due to conditions of trauma, 
coagulopathies and blood and blood vessel neoplasm. The fluid contains high 
levels of cells mainly red blood cells with PCV being above 20%.
5. Greenish discolouration of fluid: This is seen in cases of rupture and seepage of 
bile into the peritoneal cavity.
6. Milky/slightly yellowish discolouration: This describes a condition of collec-
tion of lymph in the peritoneal cavity due to trauma, infection, cancer or right-
sided heart failure. This type of exudates is turbid and opaque and is often 
described as chyle. It gives a positive result in Sudan III stain test for lipids due 
to the high level of lipid in the fluid.
4.1.4 Clinical examination (author’s personal experience)
Clinical examination is considered a useful tool in the identification of the cause 
of ascites. An elevated temperature would signify an underlying infectious or inflam-
matory condition such as bacterial tuberculosis. An elevated capillary refill time 
would signify a decreased circulatory volume as a result of cancerous or infectious 
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condition. Auscultation of the heat reveals various cardiovascular diseases such as 
muffled heart sound which is consistent with pericardial effusion and cardiac tam-
ponade. Heart murmurs or irregular heartbeats are suggestive of right-sided heart 
failure. An elevated heartbeat or tachypnoea may result from dyspnea due to cranial 
displacement of the diaphragm into the thoracic cavity. Cardiovascular abnormalities 
are confirmed through the use of electrocardiograph and echocardiography.
4.1.5 Biochemical investigation in ascites (author’s personal experience)
The determination of biochemical profile such as the liver enzymes, total protein 
level, SAAG, albumin concentration, total bilirubin and kidney analytes such as 
creatinine and urea levels is useful in the diagnosis of the cause of ascites.
4.1.6 Serum ascites albumin gradient (SAAG)
Serum ascites albumin gradient is presently the best tool in diagnosis of the 
cause of ascites especially that from portal hypertension [38]. A SAAG value of 
<1.1 g/dl or 11 g/l indicates causes of non-portal origin such as malignancy, etc. [5]. 
Gradients >1.1 g/dl or 11 g/l indicate ascites of portal hypertension.
4.1.7 Total protein
Although the traditional classification of ascites according to the transudate 
and exudate concept has almost phased out following the introduction of SAAG, it 
however still has relevance in clinical practice for comparison and prognostic value. 
Concentrations below 15 g/l are often associated with risk of spontaneous bacteria 
peritonitis in cirrhosis [5, 39].
4.1.8 Triglycerides
An elevated triglyceride concentration in ascetic fluid above 2.2 mmol/l indicates 
chylous ascites [38]. Chylous ascites is common in neoplastic cases although it may 
occur in 6% of cirrhosis [40].
4.1.9 Urea and creatinine
Elevated levels in urea and creatinine concentrations in ascetic fluid indicate 
prerenal failure due to peritoneal absorption of urea [41]. Urinary ascites is often 
associated with bladder changes and urethra obstruction [41, 42].
Figure 1. 
Removal of ascites through the linea alba in an Alsatian breed of dog.
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4.1.10 Cytology
Cytology of ascetic fluid is often indicated in suspected malignancy and idio-
pathic cases. Positive cytology is highly indicated in suspected cases of peritoneal 
carcinomatosis. The sensitivity of cytology can be enhanced by examination of 
three samples from separate paracenteses [38]. The sensitivity is also enhanced by 
prompt analysis of ascetic fluid and obtaining large volume of up to 50–1000 ml in 
patients with initial negative result.
4.1.11 Diagnostic laparotomy
Diagnostic laparotomy is indicated in cases of difficulty in identification of the 
aetiology of ascites. Often laparotomy presents adequate visual inspection of the 
peritoneal cavity and avenue for biopsy collection for histological and microbiologi-
cal studies [38]. Diagnostic laparotomy provides ground for effective diagnosis of 
peritoneal carcinomatosis, tuberculous peritonitis, etc. [43, 44].
4.1.12 Leucocyte esterase reagent strip
Several studies have shown the usefulness in the use of leucocyte esterase 
reagent strip in diagnosing spontaneous bacteria peritonitis and in urinary analysis 
with sensitivity ranging from 80 to 93% and specificity 93–98% [45]. The negative 
predictive value is markedly high from 97 to 99%, a good measure for an ideal tool 
to rule out SBP [45]. Recent development has discovered an ascite-specific reagent 
strip with a cut-off value of 250 cells/mm3 which would further enhance diagnostic 
accuracy [46].
4.1.13 Platelet indices
Increased platelet indices such as mean platelet volume and platelet distribution 
width have been observed to increase in cirrhosis. The usefulness of the platelet 
indices is yet to be fully elucidated but has shown propensity as a potential diagnos-
tic tool [47].
4.1.14 Tumour markers
The use of tumour markers such as alpha - feto protein, des-gamma-carboxy 
prothrombin, cancer antigen 125, etc. in the diagnosis of cancer in ascetic fluid 
is presently a subject of controversy among several researchers. Although the 
increased level of these markers is associated with underlying malignancies, 
elevated levels are also observed in other conditions such as pancreatitis, gastritis, 
etc. [48].
4.1.15 Imaging tools
Radiographical imaging is useful in detailing small amounts of ascetic fluid 
as well as diagnosis of aetiology of ascites [49]. Abdominal ultrasonography can 
detect as little as 100 ml of intraperitoneal fluid [50]. The sensitivity of radiogra-
phy is enhanced through the use of computed tomography which detects minute 
quantities of ascetic fluid. Radiography enhances the picture of internal organs and 
aids in detection of cirrhosis, intra-abdominal tumour and organ enlargements. 
Thickening of mesentery and bowel wall, matting of bowel loops and enlargement 
of mesenteric lymph nodes may provide a guide in the diagnosis of tuberculosis 
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peritonitis in affected patients. A contrast computed tomography (CT) may be 
used to demonstrate enhancement of peritoneal lining. Cases of cirrhosis and large 
hydrothorax can be diagnosed with the aid of scintigraphy with technetium sulphur 
colloid or radiolabelled albumin [6].
4.1.16 Bacterial culture
Spontaneous bacterial peritonitis may arise due to decreased level of compli-
ments which serve as antibacterial factors in ascetic fluid. Suspected cases of SBP 
are cultured in both aerobic and anaerobic blood media for isolation of organisms 
[51]. Cultured ascetic fluid should be subjected to sensitivity test to identify effec-
tive antimicrobiological agent in treatment.
The DNA of Mycobacterium tuberculosis in ascetic fluid can be detected using 
polymerase chain reaction in suspected cases. PCR for Mycobacterium tuberculosis 
offers a high sensitivity (94%) test compared to microscopic acid-fast bacilli smear 
(−0%) and mycobacterial culture (−50) [38].
5. General treatment options in ascites
Ascites is treated symptomatically while addressing the primary cause of the 
condition. Efforts are geared towards relieving manifesting symptoms and prevent-
ing progression of ascites. The main goal in congestive heart failure is to improve 
cardiac contractility, normalise cardiac arrhythmias and enhance cardiac output. 
Cardiac drugs such as dopamine and digoxin can be used at recommended dos-
ages in cases of congestive heart failure in dogs. Dogs with right-sided heart failure 
should be placed on cage rest and on sodium-restricted diet [52]. Paracentesis is 
applied to relieve abdominal tension on the diaphragm and enhance normal respira-
tion. Repeated paracentesis is not required except in cases of failing treatment [52]. 
Paracentesis should not exceed 1.0 kg weight per day for dogs with both ascites and 
peripheral oedema and less than 0.5 kg weight per day for patients with only ascites. 
Serum albumin sometimes is depleted during paracentesis and therefore should be 
monitored and replaced intravenously in case of depletion at the same quantity of 
fluid removed. The administration of albumin dosed at 1.5 g/kg on the first day and 
1.0 g/kg on the third day ensured renal preservation and reduced mortality [53]. In 
cases of syncope, a balanced isotonic crystalloid fluid replacement such as Plasma-
Lyte A, Normosol R and 0.9% saline may be used in resuscitation and other condi-
tions such as hypernatraemia, hyponatraemia, hypercalcemia, metabolic alkalosis or 
oliguria renal failure. Diuretics are used in addition to paracentesis to relieve ascites. 
Diuretics may be dosed once daily. Spironolactone has a half life of 24 hours and is 
given at the dose of 100 mg/day max 400 mg/day for response [54]. The dose may be 
spread out every 2 hours stat in dogs under hospitalisation and close monitoring at 
2 mg/kg × im and at 3 mg/kg × per os at night. Spironolactone could be substituted 
with either triamterene or amiloride since both drugs have good antagonistic effect 
on aldosterone action on the collecting tubules [55]. Furosemide is often the first line 
of treatment in cases of ascites with a half life of 1.5 hours and given at the dose of 
40 mg/day and max 160 mg/ day in case of nonresponders to furosemide [39]. The 
dose may also be spread in divided doses of 3 mg/kg × IV every 2 hours and at 4 mg/
kg per os at night. Bumetanide and spironolactone could be used in combination 
with furosemide at the ratio of 100:40 to reduce chances of furosemide resistance. 
The dose ratio ensures efficient natriuresis and flow of water and also reduces the 
risk of potassium deficit from the use of furosemide [39, 56]. Other diuretics such 
as torsemide and bumetanide have shown better efficacy than most diuretics [57]. 
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Torsemide has a longer half life than both furosemide and bumetanide [57]. Patient 
with cirrhotic ascites often presents with complications of SBP, portal hypertension 
and HRS [28]. Cases without such complications are described as “uncomplicated 
ascites” [58]. The standard treatment for SBP in humans involves immediate admin-
istration of third-generation cephalosporin such as intravenous ceftriaxone 1 to 2 g 
daily for 5 days [52]. The dose could be given at 1 g daily in dogs. The use of oral 
fluoroquinolones is equally effective in the treatment of SBP [59, 60]; alternatively 
piperacillin and tazobactam could be considered [61]. The choice of antibacterial 
agent depends on culture and sensitivity test to reduce problems of drug resistance. 
Antibiotic treatment is usually given for an extended period to ensure complete cure 
of the bacterial infection.
Portal hypertension is managed by the use of antihypertensive medications. A 
drug such as metolazone (Mykron, Zaroxolyn) aids in the elimination of oedema in 
congestive heart failure. It enhances sodium excretion by inhibition of sodium reab-
sorption from the distil tubules, a function which is beneficial in renal conditions 
[55]. Mannitol (Osmitrol) inhibits tubular reabsorption of electrolyte by increasing 
the osmotic pressure of glomerular filtrate and urine output [55]. Cases of recurrent 
ascites in humans from portal hypertension may require the use of TIPS [28]. TIPS 
functions as a side-to-side portacaval anastomosis between the high portal pressure 
end and low hepatic vein pressure end, thereby effectively decongesting the portal 
system which may be useful in pets. A reduction in the portal hypertension brings a 
secondary decrease in RAAS activation and consequent increase in sodium excre-
tion [62]. Persistent ascites from cirrhosis may be managed through liver transplant 
and removal of the damaged liver. The hepatic cells naturally possess high regenera-
tive capacity and can regenerate after undergoing severe degenerative condition. 
The hepatocytes in addition can perform at full capacity even with few viable cells, 
and therefore liver transplant is only required as a last resort after application of all 
remedial medications.
Renal failure is managed by controlling blood pressure with drugs; avoid the 
use of hepatotoxic medications in treatment of ascites and the use of non-steroidal 
anti-inflammatory agents (NSAIDs) such as acetaminophen. Kidney dialysis is 
recommended in severe kidney damage. A continuous venovenous haemodialysis 
(CVVHD) is recommended compared to intermittent renal dialysis.
Cases of complications of encephalopathies from hepatic failure are best man-
aged in intensive care units (ICU) [18]. Cases of early complication of encephalopa-
thy may be treated as outpatient; nevertheless such a patient is closely monitored 
for further deterioration to grade II encephalopathy which would require prompt 
transfer to an intensive care unit. Such a patient is placed on routine check on 
mental balance, and signs of restlessness could be slightly sedated with low dose of 
short-acting benzodiazepines. Patients under sedation are placed on undisturbed 
bed rest avoiding extensive movement which may enhance chances of intracranial 
pressure/hypertension. Dyspnea is prevented in late encephalopathy through place-
ment of intratracheal intubation to avoid further complications of aspiration pneu-
monia. The conditions of cerebral oedema and intracranial hypertension manifest 
at the late phase of encephalopathy and are prevented through routine checks on 
the patient’s renal parameters; biochemical profile including liver enzymes, total 
protein, glucose, electrolytes and acid/balance; and neurological evaluations 
for signs of elevated levels [4]. Cases of severe bleeding result from problems of 
coagulopathies which can be treated by addressing the coagulopathy through 
transfusion of coagulation products such as fresh frozen plasma and platelets and 
administration of vitamin K. Severe conditions may be boosted by transfusion of 
packed red blood cells. Continuous bleeding after massive replacement infusions 
may indicate possible retroperitoneal bleeding [18]. A good number of herbal and 
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antioxidant medications have shown to be beneficial in the treatment of ascites of 
hepatic origin. The use of these drugs remains controversial, but despite this the 
drug N-acetylcysteine and Silybum marianum still remain the drug of choice in the 
treatment of hepatic damage from acetaminophen toxicity and hepatic dysfunction, 
respectively [63].
Conclusion: Ascites is a disease condition commonly seen in pets of various age 
brackets with high incidences occurring in middle-aged dogs. Ascites is a common 
manifestation of a decompensate cirrhosis, cardiac diseases and several other aeti-
ologies and is best diagnosed through established standard procedures of physical 
and clinical examinations, complete blood picture, cytology and various biochemi-
cal analyses. Recent novel techniques such as platelet indices, leucocyte esterase 
reagent strip, tumour markers, bacterial DNA, cytokines and other proteins are 
available for the advancement of biochemical laboratory techniques and efficient 
diagnosis of ascites. Treatment is centred on effective diagnosis of the aetiology.
Acknowledgements
I sincerely acknowledge the God Almighty for His enablement bestowed upon 
me during the course of this write-up.
Appendix
dyspnea  difficulty in breathing
encephalopathies degenerative condition in the brain
cholestasis  obstruction of the bile duct
haemolysis  red blood cell destruction
gastroenterology study of both the stomach and intestines
haematology  study of the blood
neurology  study of the nervous tissues
ascites  accumulation of fluid in the abdominal cavity
effusion  accumulation of fluid in the abdominal cavity
arrhythmia  irregular heartbeat
tamponade  closure or blockage especially to stop bleeding
coagulopathy  problem with blood clotting mechanism
conjugated  reversibly combined with a compound
unconjugated  compound in its natural form
opaque  not transparent, cloudy, filmy
aetiology  the cause of a disease condition
vascularisation  area supplied with blood vessels
transudate  fluid produced from increased pressure in the hepatic,   
 portal vein (>8 mmHg) usually around 20 mmHg, low in   
 protein (<30 g/L), low in LDH, high pH, normal glucose   
 and fewer cells
exudate  fluid actively secreted from inflammation or malignancy,   
 rich in protein, lactate dehydrogenase, low pH (<7.30), low  
 glucose level and large numbers of white blood cells
renal  pertains to the kidney
hepatorenal syndrome condition that affects both the liver and kidney
Silybum marianum active compound in milk thistle herbal preparation
Amanita phalloides a poisonous species of mushroom
idiopathic  unknown origin
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